Lipoglycopeptide - PDFSEARCH.IO - Document Search Engine

Lipoglycopeptide
Results: 8

#	Item
1	Theravance and Astellas to Collaborate on Telavancin, Investigational Antibiotic for Serious Infections SOUTH SAN FRANCISCO, CA and TOKYO, JAPAN/ November 7, [removed]Theravance, Inc., and Astellas Pharma Inc. announced t Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:56:16 Pharmacology Astellas Pharma Medicine Lipoglycopeptide Methicillin-resistant Staphylococcus aureus Pharmaceutical industry Vancomycin Antibiotics Telavancin Pharmaceutical sciences
2	Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections in Europe TOKYO, JAPAN AND SOUTH SAN FRANCISCO, CA/October 28, 2009 Add to Reading List Source URL: www.astellas.com Language: English - Date: 2009-10-28 20:07:57 Bacterial diseases Antibiotics Staphylococcaceae Pathogenic bacteria Telavancin Glycopeptide antibiotics Lipoglycopeptide Methicillin-resistant Staphylococcus aureus Astellas Pharma Bacteria Microbiology Medicine
3	Theravance and Astellas Add Japan to Collaboration on Telavancin, Investigational Antibiotic for Serious Infections SOUTH SAN FRANCISCO, CA and TOKYO, JAPAN/July 18, [removed]Theravance, Inc. (NASDAQ: THRX), and Astellas Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-19 00:50:37 Astellas Pharma Lipoglycopeptide Methicillin-resistant Staphylococcus aureus Pharmaceutical industry Pharmacology Medicine Antibiotics Telavancin Pharmaceutical sciences
4	FDA Briefing Document: Anti-Infective Drugs Advisory Committee Meeting Add to Reading List Source URL: www.fda.gov Language: English Health Lipoglycopeptide Amines Durata Therapeutics Clinical trial Methicillin-resistant Staphylococcus aureus Methadone Chemistry Dalbavancin Pharmaceutical sciences
5	Dalbavancin for Injection Anti-Infective Drugs Advisory Committee Durata Therapeutics International B.V. NDA[removed] Add to Reading List Source URL: www.fda.gov Language: English Microbiology Staphylococcaceae Bacterial diseases Eli Lilly and Company Antibiotics Dalbavancin Durata Therapeutics Methicillin-resistant Staphylococcus aureus Lipoglycopeptide Bacteria Biology Glycopeptide antibiotics
6	Introductory Remarks - Anti-Infective Drugs Advisory Committee Meeting for Dalbavancin March 31, 2014 John Alexander, MD, MPH Medical Team Leader, DAIP Add to Reading List Source URL: www.fda.gov Language: English Antibiotics Organofluorides Lipoglycopeptide Biology Linezolid Methicillin-resistant Staphylococcus aureus Microbiology Medicine Glycopeptide antibiotics Durata Therapeutics Dalbavancin
7	Initial approval[removed]Most recent modification[removed]NDA[removed]and NDA[removed]VIBATIV (telavancin) for injection [Lipoglycopeptide] Add to Reading List Source URL: www.fda.gov Language: English Pharmacist American Society of Health-System Pharmacists Clinical pharmacy Medicine Science Health Email Pharmacy
8	Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization Add to Reading List Source URL: www.farm.ucl.ac.be Language: English - Date: 2009-10-27 07:38:44

UPDATE